In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop
Clinical trial NCT06493799 · RECRUITING
Trial details
- NCT number
- NCT06493799
- Sponsor
- Green Cross Wellbeing
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-03-31
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.